Form 4 for PCVX Vaxcyte, Inc.
Accepted 2022-10-26 00:00:00 ET · period of report 2022-10-24 · accession 0001209191-22-054664 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-10-26 | 2022-10-24+ | PCVX | Lukatch Heath | Dir | M - OptEx | $16.00 | +7,015 | 7,125 | +6,377% | +$112.2K |
| DM | 2022-10-26 | 2022-10-24+ | PCVX | Lukatch Heath | Dir | S - Sale+OE | $36.90 | -7,015 | 3,125 | -69% | -$258.9K |
| DM | 2022-10-26 | 2022-10-24+ | PCVX | Lukatch Heath | Dir | D - Sale to Iss | $0.00 | -7,015 | 37.0K | -16% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-10-24 | M | A | 3,015 | $16.00 | 6,140 | D | — | — | |
| 2 | Common | Common Stock | 2022-10-26 | S | D | 4,000 | $38.25 | 3,125 | D | — | — | |
| 3 | Common | Common Stock | 2022-10-26 | M | A | 4,000 | $16.00 | 7,125 | D | — | — | |
| 4 | Common | Common Stock | 2022-10-24 | S | D | 3,015 | $35.11 | 3,125 | D | — | — | |
| 5 | Derivative | Stock Option (right to buy) | 2022-10-26 | D | D | 4,000 | $0.00 | 32,985 | D | $16.00 · — to 2030-06-10 | 4,000 Common Stock | (F2) 1/3 of the shares subject to the option vest on June 11, 2021, and 1/36 of the shares vest monthly thereafter. |
| 6 | Derivative | Stock Option (right to buy) | 2022-10-24 | D | D | 3,015 | $0.00 | 36,985 | D | $16.00 · — to 2030-06-10 | 3,015 Common Stock | (F2) 1/3 of the shares subject to the option vest on June 11, 2021, and 1/36 of the shares vest monthly thereafter. |